Joint initiatives with the American Vasculitis Clinical Research Consortium (VCRC) and OMERACT (Outcome Measures in Rheumatoid Arthritis Controlled Trials) are advancing the assessment of disease activity, damage and quality of life in vasculitis.
An extended follow-up of patients recruited into EUVAS trials has been performed since 2005. The first reports were accepted for publication in 2011.
The largest therapeutic trial in ANCA-associated vasculitis was lunched in 2010 recruiting patients on three continents in collaboration with the VCRC.
Information regarding active and completed clinical trials may be accessed here!